Do you have Myasthenia gravis and had an adverse reaction to the meningococcal vaccine required before starting the MG treatments Ultomiris, Rystiggo, Zilbrysq, and Soliris?
It's crucial to know that specific Myasthenia gravis treatments, including the biologic type treatments Ultomiris, Rystiggo, Zilbrysq, and Soliris, can increase the risk of developing life-threatening meningococcal infections. Therefore, it is absolutely essential for anyone considering these medications to receive meningococcal vaccinations before their first dose. "It is recommended to get a meningococcal vaccine at least 2 weeks before your first dose of Soliris, Ultomiris, or Zilbrysq. You should get regular booster shots. Your doctor may also recommend antibiotics to avoid meningococcal disease" https://myasthenia-gravis.com/biologics.
According to the CDC, "All 11 to 12 year olds should receive a meningococcal conjugate vaccine. Since protection wanes, CDC recommends a booster dose at age 16 years. The booster dose provides protection during the ages when adolescents are at highest risk of meningococcal disease...CDC also recommends a booster dose for those at increased risk due to an outbreak if 5 or more years have passed since receiving MenACWY.".MenACWY Vaccination and MenB Vaccination are recommended before starting specific MG treatments that increase the risk of developing life-threatening meningococcal infections, but "If a patient is receiving MenACWY and MenB vaccines at the same visit, MenABCWY may be given instead" https://www.cdc.gov/vaccines/vpd/mening/hcp/recommendations.html#:~:text=Adolescents%20who%20receive%20their%20first,booster%20doses%20every%205%20years.